
LUMA Vision is a company that creates connected intra-vascular medical devices to aid in the treatment of cardiac arrhythmias. Through advanced four-dimensional imaging and artificial intelligence (AI), the company improves the way EP and structural heart interventions are treated, allowing doctors to perform cardiac treatments that improve patient outcomes, increase procedural safety, and reduce healthcare system costs.

LUMA Vision is a company that creates connected intra-vascular medical devices to aid in the treatment of cardiac arrhythmias. Through advanced four-dimensional imaging and artificial intelligence (AI), the company improves the way EP and structural heart interventions are treated, allowing doctors to perform cardiac treatments that improve patient outcomes, increase procedural safety, and reduce healthcare system costs.
Product: 4D imaging and navigation platform for electrophysiology (EP) and structural heart interventions
Founded / HQ: 2017 — Harold's Cross, Dublin, Ireland
Funding: Series A; total funding USD 53,980,000; Dec 2023 grant of USD 6,000,000
Founders: Fionn Lahart (Co‑Founder & CEO); Christoph Hennersperger (Co‑Founder & CTO)
Employees: 79
Improving diagnosis, navigation and treatment during electrophysiology and structural heart procedures.
2017
Medical devices (cardiac imaging/navigation)
USD 6,000,000
Recorded grant round (Dec 2023).
Series A reported with participation from Bayern Kapital and Atlantic Bridge.
“Backed by institutional life‑science investors including imec.xpand and EQT Life Sciences; participation from Bayern Kapital and Atlantic Bridge; received grant funding from Enterprise Ireland and the European Innovation Council.”